We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Quidel Licenses Molecular Antiviral Resistance and Influenza Detection Technology

By Labmedica staff writers
Posted on 24 Jul 2007
Print article
Quidel Corp. (San Diego, CA, USA) announced exclusive, worldwide licenses to the antiviral resistance microarray-based influenza detection (AVR-Chip) and the microarray-based influenza B detection technology (BChip).

Both technologies were developed by scientists at the University of Colorado at Boulder (CU-Boulder; Boulder, CO, USA) in collaboration with the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA).

The AVR-Chip is useful in identifying mutations that may confer resistance to antiviral reagents and facilitate proper influenza treatment decisions. The ability to identify antiviral susceptibility is important for global monitoring of influenza patterns, and for directing physicians toward better treatment decisions.

The BChip can detect influenza B virus strains, for example, B/Victoria/2/87 and B/Yamagata/16/88. In a recent study of 62 influenza B virus samples from 19 countries, dating from 1945 to 2005, as well as five negative control samples, the BChip exhibited 97% sensitivity and 100% specificity, with no false-positives. This information is critical for preparing seasonal influenza vaccines.

Caren Mason, president and CEO of Quidel commented, Exclusive access to molecular-based technologies for influenza B diagnostics, and for detection of antiviral resistance, greatly complements our ongoing progress with our MChip technology for influenza A. These licenses also reinforce our commitment to market leadership in rapid point-of-care influenza diagnostics.

Quidel's portfolio currently includes tests that aid in the diagnosis of several diseases or conditions, including influenza, respiratory syncytial virus, fecal occult blood, Streptococcus A, Helicobacter pylori, Chlamydia, pregnancy, and bacterial vaginosis.


Related Links:
Quidel
University of Colorado at Boulder
U.S. Centers for Disease Control and Prevention
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Centrifuge
Centrifuge 5430/ 5430 R
New
PSA Test
Human Semen Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.